1
|
Medina PB, Armon S, Bin Abdul Aziz MF, Cheong IH, de Leon MP, Drobysz S, Fikry Bin Haji Abdul Momin MH, Garcia DL, Iskandriati D, Kozlakidis Z, Cui L, Mao S, Miranda ME, Mya KM, Nallenthiran L, Obusan MC, Phimmakong K, Sabai P, Saejung C, Sathasivam HP, Jafar FLB, Vitor RJS, Yabes AM, Calaor AB, Vijayan V, Lin RTP. A Review of Regulatory Frameworks for Biobanking in Southeast Asia. Biopreserv Biobank 2024. [PMID: 39248001 DOI: 10.1089/bio.2024.0044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/10/2024] Open
Abstract
Southeast Asian countries are at the forefront of public health pressures due to a confluence of factors such as population growth, urbanization, environmental pollution, and infectious diseases (re)emergence. Therefore, the ability to be able to conduct research addressing local and regional needs is of paramount importance. As such, biobanking activities, the standardized collection of biological samples, and associated data, developed over the past few decades supporting ongoing biomedical and clinical research, as well as surveillance are of critical importance. However, the regulatory landscape of biobanking is not widely understood and reported, which this narrative review aims to address for the ASEAN member states. It is evident that there are specific regulatory arrangements within each ASEAN member state, which though may be sufficient for the current level of operations, are unlikely to support a regional sharing of biological samples, data, and eventually benefits from the conducted research. Additionally, legacy and often-overlapping regulatory frameworks exist, which raise the need of an eventual consolidation under a single framework. Thus, this field requires further study as well as the creation of viable, practical proposals that would allow for biobanking harmonization and thus the exchange of biological samples and data to be achieved regionally, if not further afield.
Collapse
Affiliation(s)
- Plebeian B Medina
- Department of Health, Research Institute for Tropical Medicine, Manila, Philippines
| | - Subasri Armon
- Hospital Kuala Lumpur, Ministry of Health, W.P. Kuala Lumpur, Kuala Lumpur, Malaysia
| | | | - Io Hong Cheong
- School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | | | - Sonia Drobysz
- The Verification Research, Training and Information Centre, London, United Kingdom
| | | | | | | | - Zisis Kozlakidis
- International Agency for Research on Cancer, World Health Organization, Lyon, France
| | - Lin Cui
- National Public Health Laboratory, Ministry of Health, Singapore, Singapore
| | - Seanghorn Mao
- Institute of Explore and Experiment on Substance of Chemical Weapon of National Authority Chemical Weapons Convention (NACW), Phnom Penh, Cambodia
| | | | - Khin Mar Mya
- Biotechnology Research Department, Ministry of Education, Kyaukse, Myanmar
| | | | | | - Kongchay Phimmakong
- Department of Science, Ministry of Science and Technology, Vientiane, Lao PDR
| | - Phyu Sabai
- Laboratory Biorisk Consultancy & Training Pte. Ltd., Singapore, Singapore
| | | | | | | | - Rodel Jonathan S Vitor
- National Training Center for Biosafety and Biosecurity, National Institutes of Health, University of the Philippines Manila, Manila, Philippines
| | - Ailyn M Yabes
- University of the Philippines Manila, Quezon City, Philippines
| | | | - Viji Vijayan
- Medical School, Duke-National University of Singapore, Singapore, Singapore
| | - Raymond T P Lin
- National University Hospital Singapore, National University of Singapore, Singapore, Singapore
| |
Collapse
|